中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2012年
3期
337-338
,共2页
吴尉%钟志强%郑著家%张颖%王莹
吳尉%鐘誌彊%鄭著傢%張穎%王瑩
오위%종지강%정저가%장영%왕형
胃肿瘤%抗肿瘤联合化疗方案%紫杉醇%奥沙利铂
胃腫瘤%抗腫瘤聯閤化療方案%紫杉醇%奧沙利鉑
위종류%항종류연합화료방안%자삼순%오사리박
Stomach neoplasms%Antineoplastic combined chemotherapy protocols%Docetaxel%Oxaliplatin
目的 比较新辅助化疗方案紫杉醇(PTX)联合氟尿嘧啶(5-Fu)/甲酰四氢叶酸钙(LV)(PF方案)和奥沙利铂(L-OHP)联合5-Fu/LV(FOLFOX方案)用于进展期胃癌综合治疗的近期疗效.方法 60例临床确诊的进展期胃癌(Ⅲ~Ⅳ期)患者随机分为PF组和FOLFOX组,每组各30例,分别采用PF和FOLFOX方案进行新辅助化疗3周期,比较两种化疗方案对进展期胃癌的近期疗效和不良反应.结果 PF组化疗后总有效率77.67%,FOLFOX组总有效率50.00%,两组差异有统计学意义(x2=4.59,P<0.05);两组白细胞减少、转氨酶升高及恶心和腹泻程度相似;PF组脱发程度较重,但两组差异无统计学意义(P >0.05);FOL-FOX组末梢神经感觉异常明显,两组差异有统计学意义(x2=5.08,P<0.05).结论 PF化疗方案近期疗效显著,耐受性好.
目的 比較新輔助化療方案紫杉醇(PTX)聯閤氟尿嘧啶(5-Fu)/甲酰四氫葉痠鈣(LV)(PF方案)和奧沙利鉑(L-OHP)聯閤5-Fu/LV(FOLFOX方案)用于進展期胃癌綜閤治療的近期療效.方法 60例臨床確診的進展期胃癌(Ⅲ~Ⅳ期)患者隨機分為PF組和FOLFOX組,每組各30例,分彆採用PF和FOLFOX方案進行新輔助化療3週期,比較兩種化療方案對進展期胃癌的近期療效和不良反應.結果 PF組化療後總有效率77.67%,FOLFOX組總有效率50.00%,兩組差異有統計學意義(x2=4.59,P<0.05);兩組白細胞減少、轉氨酶升高及噁心和腹瀉程度相似;PF組脫髮程度較重,但兩組差異無統計學意義(P >0.05);FOL-FOX組末梢神經感覺異常明顯,兩組差異有統計學意義(x2=5.08,P<0.05).結論 PF化療方案近期療效顯著,耐受性好.
목적 비교신보조화료방안자삼순(PTX)연합불뇨밀정(5-Fu)/갑선사경협산개(LV)(PF방안)화오사리박(L-OHP)연합5-Fu/LV(FOLFOX방안)용우진전기위암종합치료적근기료효.방법 60례림상학진적진전기위암(Ⅲ~Ⅳ기)환자수궤분위PF조화FOLFOX조,매조각30례,분별채용PF화FOLFOX방안진행신보조화료3주기,비교량충화료방안대진전기위암적근기료효화불량반응.결과 PF조화료후총유효솔77.67%,FOLFOX조총유효솔50.00%,량조차이유통계학의의(x2=4.59,P<0.05);량조백세포감소、전안매승고급악심화복사정도상사;PF조탈발정도교중,단량조차이무통계학의의(P >0.05);FOL-FOX조말소신경감각이상명현,량조차이유통계학의의(x2=5.08,P<0.05).결론 PF화료방안근기료효현저,내수성호.
Objective To observe the recent effects and toxicity in advanced gastric carcinoma by two kinds of neoadjuvant chemotherapies ( PF and FOLFOX).Methods A total of 60 patients with advanced gastric cancer ( Ⅲ ~ Ⅳ ),they were randomly divided into 2 groups; PF group ( 30 cases) and FOLFOX group ( 30 cases).All patients were given 3 cycles of docetaxel or L-OHP chemotherapy preoperatively,to observe the recent effects and toxicity in advanced gastric carcinoma.Results The total effective rate in PF group was 77.67%,while it was 50.00% in FOLFOX group,it had significant difference between in two groups ( x2 =4.59,P < 0.05 ).There is no difference in the incidence of neutropenia,transaminase elevation,nausea and diarrhea two groups.The incidence of hair loss in PF group is higher than in FOLFOX group,but there is no difference between two groups; The incidence of peripheral nerve paresthesia in FOLFOX group is higher than that in PF group( x2 =5.08,P <0.05).Conclusion PF as neoadjuvant chemotherapy is a very effective and well-tolerated regimen in patients with advanced gastric cancer.